Advances in applying DNA methylation as the biomarkers of hepatocellular carcinoma / 中华检验医学杂志
Chinese Journal of Laboratory Medicine
; (12): 79-81, 2016.
Article
em Zh
| WPRIM
| ID: wpr-489075
Biblioteca responsável:
WPRO
ABSTRACT
Hepatocellular carcinoma (HCC) is a malignant tumor with high morbidity and high mortality.Early diagnosis is the key for HCC treatment.DNA methylation is one of the important mechanisms of epigenetic genetics.To investigate the mechanism of DNA methylation can provide a theoretical basis for the diagnosis of HCC,and the methylation level of the specific genes can also be used as the biomarkers of HCC for the early diagnosis and prognosis evaluation.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Screening_studies
Idioma:
Zh
Revista:
Chinese Journal of Laboratory Medicine
Ano de publicação:
2016
Tipo de documento:
Article